Showing results (1-10 of 2,507) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|December 12, 2022
Poly-lymphomatous Syndrome With Concurrent or Sequential Hodgkin and Non-Hodgkin lymphomaMadiha Iqbal, Liuyan Jiang, Ke David Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2022
PD-1 Blockade After Avelumab in Relapsed/Refractory Classical Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, James Godfrey, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2022
SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS LymphomaJillian Simard, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2022
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia RegistryChantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 24, 2020
Burden of Treatment Among Older Adults With Newly Diagnosed Multiple MyelomaHira S Mian, Mark A Fiala, Tanya M Wildes
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2020
Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T CellsXiaojuan Chen, Ying Wang, Min Ruan, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 30, 2020
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 CasesYuting Yan, Rui Lv, Wenjie Xiong, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 13, 2021
Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic ReviewLaeth L George, Saarang R Deshpande, Matthew J Cortese, et al.
Pageof 251